Diabetes and COVID-19: Diseases of racial, social and glucose intolerance

Diabetes and coronavirus disease 2019 (COVID-19) are worldwide pandemics that have had a major impact on public health throughout the globe. Risk factors for developing diabetes and having adverse outcomes of COVID-19 appear to be similar; metabolic factors (such as obesity), non-White ethnicity and poorer socioeconomic status appear to be risk factors for both. Diabetes and COVID-19 have a significant effect on populations adversely affected by health inequality. Whilst we hope that COVID-19 will be mitigated by widespread use of vaccines, no such prospect exists for mitigating the pandemic of diabetes. In this brief opinion review, I compare risk factors for diabetes and adverse outcomes of COVID-19 and argue that tackling health and social inequality is likely to play a major role in solving the global diabetes pandemic and improve outcomes of COVID-19.

Automated summary

Diabetes and COVID-19 share similar risk factors, including metabolic factors, ethnicity, and socioeconomic status, significantly impacting populations affected by health inequality. Tackling health and social inequality may play a crucial role in addressing the global diabetes pandemic and improving outcomes of COVID-19.